The EU market accounts for 25% of all global medicines sales, when we break away and become a smaller separate market, companies may very well priorities bigger markets to introduce their medicines into over the UK. The NHS may as a result struggle to access medicines and combined with the drop, in value of the pound against the euro and the dollar what we can access will cost more. The NHS is already struggling to work within its budgets and targets this will make things worse. The NHS must be considered in future Brexit negations, or we may see shortages of medicines in the future.
The UK may see medicine shortages and delays in the introduction of new medicines after Brexit.
by Jackie (née Heneghan) Peck | Jun 12, 2017 | Brexit, NHS
Recent Posts
Testimonials
“A lot of valuable information to digest! Thank you.” Anna Drys – Course rating 9/10
GDP Training
“My experience working with Steven has been calm and reassuring. I have struggled to find specific requirements for API distribution from my previous consultant and the Green Guide. I start working with Steven shortly after taking an API training course at PCL, the consultation is beyond my expectation, he helps me identify my specific set of issues quickly and advise me how I should address them to achieve compliance. In the short time I am working with Steven gives me clarity that I hav… Read more
Consultancy Services
“Very clear, simple to follow. Interactive. Helpful.” Ade – Rating 9/10
Export Training
“The gem is the trainer’s real world prospect on MHRA Inspector’s expectations” Cogent Online Training – July 2021
Cogent - July 2021
“Very informative and very helpful. Brian was very professional and very patient with our numerous questions. Thank you.” Catherine Hodges – Course Rating 10/10
GDP & RP
I attended one of the first virtual GDP Responsible Person Cogent “Gold Standard” training sessions due to the Covid-19 social distancing requirements. regardless of the circumstances the training was well organised and delivered to the required standard. This is why I recommended my associates to utilise PCL. Thank you Ryan, Sally, Adel and Jackie. Goncalo Sousa – Quality Head UK at the Janssen Pharmaceutical Companies of Johnson & Johnson 05/05/2020
Cogent Gold Standard GDP Online Training
“Kim was able to give good examples, in order to understand. She would also ask us specific questions and if we didn’t understand she would word it in a different way which really helped me to understand GDP.” Suzi – Course Rating 8/10
GDP Training
“Well structured and presented course. Puveshni was very knowledgeable in the field and benefited her experience.” Abdirahman – Course Rating 10/10
GDP Training
“Very informative and John was able to demonstrate a great knowledge of export. Having already completed Pharmacy Consulting’s GDP training, I was able to understand the content and what John was explaining in regard to export” Anonymous – Rating 9/10
Export Training
I am new to GDP and the trainer was very patient with my endless questions and answered them all with rounded practical answers that i can take back to my workplace and implement. Shirley Clifton – Ashford and St Peters Hospital
GDP/RP Training